CD274 and neoplasm: Researchers designed a multifunctional nanohydrogel system incorporating the following components: a) a core-shell structure for separately encapsulating tumor antigens and TLR agonists; b) a pH-responsive outer layer for triggering content release; c) surface-modified PD-L1 antibodies (136).